Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma

Journal of Oral and Maxillofacial Surgery

Volumn 56, Issue 12, 1998, Pages 1390-1393

  Hoffmann, Jürgen ^a   Munz, Adelheid ^a   Krimmel, Michael ^a   Alfter, Günter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTRAOPERATIVE PERIOD; MICROPARTICLE ENZYME IMMUNOASSAY; MOUTH CARCINOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA;

EID: 0031727762     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(98)90400-1     Document Type: Article

References (22)

1. Walther EK, Dahlmann N, Gorgulla HT: Tumor markers in the diagnosis and follow-up of head and neck cancer: Role of CEA, CA 19-9, SCC, TK, and dTTPase. Head Neck 15:230, 1993
2. Kurokawa H, Tsuru S, Okada M, et al: Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22:35, 1993
3. Pectasides D, Bourazanis J, Economides N, et al: Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancer. Int J Biol Markers 8:81, 1993
4. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40:1621, 1977
5. Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121:439, 1964
6. Munck WE, Kuylenstierna R, Lindholm J, et al: Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus. Anticancer Res 10:703, 1990
7. Bast RC, Klug TL, St John E, et al: A radioimmunoassay using a monoconal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883, 1983
8. Fiore M, Mitchell J, Doan T, et al: The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem 34:1726, 1988
9. Hedin A, Carlsson L, Berglund A, et al: A monoclonal antibody-enzyme immunoassay for serum carcinoembryonic antigen with increased specificity for carcinomas. Proc Natl Acad Sci U S A 80:3470, 1983
10. Mogensen O, Mogensen B: Measurement of CA 125 by an automated microparticle enzyme immunoassay: Comparison with a manual enzyme immunoassay. Scand J Clin Lab Invest 52:507, 1992
11. Kato H, Tamai K, Magaya T, et al: Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer. Gan-No-Rinsho 31:594, 1985 (suppl 6)
12. Magnani JL, Brockhaus M, Smith DF, et al: A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55, 1981
13. Bast RC, Feeney M, Lazarus H, et al: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331, 1981
14. Johnson J, Wagner R, Eibling D: Radioimmunoassay for SCC antigen in the diagnosis of squamous cell carcinoma of the head and neck: A preliminary report. Excerpta Medica 94:112, 1987
15. Eibling DE, Johnson JT, Wagner RL, et al: SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope 99:117, 1989
16. Clasen B, Pere P, Senekowitsch R, et al: Das plattenepithelkarzinomassoziierte Antigen (SCC) als Tumormarker bei der Initialdiagnostik von Karzinomen des Kopf-Hals-Gebietes. Ergebnisse einer prospektiven Studie nach 24 Monaten. Laryngorhinootologie 69:275, 1990
17. Screm MC, Grandis S, Cartei G, et al: Detection of five circulating antigens in patients with head and neck squamous cell carcinoma. Int J Biol Markers 4:35, 1989
18. Schneider M, Demard F, Chauvel P: Carcinoembryonic antigen determinations in head and neck cancer. Excerpta Medica 94:384, 1987
19. Myers RE, Sutherland DJ, Meakin JW: Carcinoembryonic antigen in breast cancer. Cancer 42:1520, 1978
20. Mach J, Jaeger P, Bertholet M: Detection of recurrence of large-bowel carcinoma by antigen (CEA). Lancet 2:535, 1974
21. Gustafsson H, Franzen L, Grankvist K: Glycoprotein tumor markers in head and neck neoplasms. J Cancer Res Clin Oncol 114:394, 1988
22. Zöller J, Fiehn W, Mende U, et al: Die diagnostische Wertigkeit der Tumormarker "CEA," "Ca 19-9," "Ca 125," "Ca 15-3" sowie "SCC" für die Erkennung von Rezidiven bei Patienten mit Kopf-Hals-Tumoren. Dtsch Z Mund Kiefer Gesichtschir 14:254, 1990